Skip to main content

aprepitant

Generic: APREPITANT·Brand: APONVIE, APREPITANT, CINVANTI, EMEND, Emend

aprepitant: 1 clinical trial tracked.

aprepitant evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about aprepitant, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (1)

A Phase 2 Open-Label Study of HTX-011 Via Individualized Dosing Administration for Postoperative Analgesia Following Unilateral Simple Bunionectomy

NCT03718039Registry updated 2026-03-02·Phase 2
Completed

Primary endpoint: Mean Area Under the Curve (AUC) of the NRS-A (Windowed Worst Observation Carried Forward) Pain Intensity Scores

Interventionalopen78 enrolledStarted 2018-10Completion 2019-031 site · United StatesHeron Therapeutics